Spirax Group plc (LON:SPX)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX | Market Cap | 5.36B +4.1% |
| Revenue (ttm) | 1.74B +5.1% |
| Net Income | 198.20M +21.9% |
| EPS | 2.68 +21.9% |
| Shares Out | 73.80M |
| PE Ratio | 27.05 |
| Forward PE | 21.28 |
| Dividend | 1.70 (2.34%) |
| Ex-Dividend Date | Oct 15, 2026 |
| Volume | 146,217 |
| Open | 7,330.00 |
| Previous Close | 7,230.00 |
| Day's Range | 7,140.00 - 7,330.00 |
| 52-Week Range | 5,950.00 - 8,050.00 |
| Beta | 1.11 |
| Analysts | Buy |
| Price Target | 8,100.28 (+11.57%) |
| Earnings Date | Mar 9, 2027 |
About Spirax Group
Spirax Group plc provides thermal energy and fluid technology solutions in Europe, the Middle East, Africa, the Asia Pacific, and the Americas. It operates through three segments: Steam Thermal Solutions, Electric Thermal Solutions, and Watson-Marlow Fluid Technology Solutions. The company offers industrial and commercial steam systems, including condensate management, controls, and thermal energy management products and solutions for heating, curing, cooking, drying, cleaning, sterilizing, space heating, humidifying, vacuum packing, and produc... [Read more]
Financial Performance
In 2025, Spirax Group's revenue was 1.70 billion, an increase of 2.26% compared to the previous year's 1.67 billion. Earnings were 163.40 million, a decrease of -14.54%.
Financial StatementsAnalyst Summary
According to 18 analysts, the average rating for SPX stock is "Buy." The 12-month stock price target is 8,100p, which is an increase of 11.57% from the latest price.
News
Spirax Group price target lowered to 8,400 GBp from 10,500 GBp at UBS
UBS lowered the firm’s price target on Spirax Group (SPXSF) to 8,400 GBp from 10,500 GBp and keeps a Buy rating on the shares.
Spirax Group price target raised to 8,600 GBp from 7,800 GBp at JPMorgan
JPMorgan analyst Chitrita Sinha raised the firm’s price target on Spirax Group (SPXSF) to 8,600 GBp from 7,800 GBp and keeps a Neutral rating on the shares. Published first on…
Spirax Group price target raised to 8,955 GBp from 8,740 GBp at Jefferies
Jefferies analyst Andy Douglas raised the firm’s price target on Spirax Group (SPXSF) to 8,955 GBp from 8,740 GBp and keeps a Buy rating on the shares. Spirax’s H1 interim…
Spirax Group Earnings Call Transcript: H1 2026
Resilient first-half performance with 5% organic sales and 6% profit growth, well ahead of IP. Strong order books and momentum across all segments support confidence in full-year guidance and medium-term margin targets. Continued investment in sales, digital, and operational improvements underpins future growth.
Spirax Group Quarterly report: H1 2026
Spirax Group has published its H1 2026 quarterly earnings report on August 11, 2026.
Spirax Group Slides: H1 2026
Spirax Group has posted slides in relation to its H1 2026 quarterly earnings report, which was published on August 11, 2026.
Spirax Group Earnings release: Trading update
Spirax Group released its earnings on May 13, 2026, summarizing the period's financial results.
Spirax Group upgraded to Outperform from Neutral at BNP Paribas
BNP Paribas upgraded Spirax Group (SPXSF) to Outperform from Neutral with an 8,350 GBp price target ahead of the Q1 report. The firm says the company’s compares are low for…
Spirax Group price target raised to 6,800 GBp from 6,000 GBp at RBC Capital
RBC Capital raised the firm’s price target on Spirax Group (SPXSF) to 6,800 GBp from 6,000 GBp and keeps an Underperform rating on the shares.
Spirax Group Earnings Call Transcript: H2 2025
Organic sales grew 5% and adjusted operating profit rose 6%, with all segments improving margins despite macroeconomic headwinds. Restructuring delivered GBP 40 million in annualized savings, funding investments in digital and growth. 2026 guidance targets mid-single-digit organic growth and further margin expansion.
Spirax Group Annual report: H2 2025
Spirax Group has published its H2 2025 annual report on March 10, 2026.
Spirax Group Annual report: H2 2025
Spirax Group has published its H2 2025 annual report on March 10, 2026.
Spirax Group Slides: H2 2025
Spirax Group has posted slides in relation to its H2 2025 quarterly earnings report, which was published on March 10, 2026.
Spirax Group price target raised to 7,350 GBp from 7,000 GBp at Berenberg
Berenberg raised the firm’s price target on Spirax Group (SPXSF) to 7,350 GBp from 7,000 GBp and keeps a Hold rating on the shares.
Spirax Group Earnings release: Trading update
Spirax Group released its earnings on November 13, 2025, summarizing the period's financial results.
Spirax Group Earnings Call Transcript: H1 2025
Organic sales and profit growth outpaced industrial production, with strong demand in biofarm, semicon, and process industries. Margins improved across all segments, restructuring is on track, and guidance for full-year growth is reiterated despite macroeconomic headwinds.
Spirax Group Quarterly report: H1 2025
Spirax Group has published its H1 2025 quarterly earnings report on August 12, 2025.
Spirax Group Slides: H1 2025
Spirax Group has posted slides in relation to its H1 2025 quarterly earnings report, which was published on August 12, 2025.
Spirax Group Earnings release: Trading update
Spirax Group released its earnings on May 14, 2025, summarizing the period's financial results.
Spirax Group Earnings Call Transcript: H2 2024
Organic sales grew 4% year-over-year, outpacing global IP, with all segments contributing and margins maintained despite macro headwinds. 2025 guidance targets similar organic growth, margin improvement, and continued investment in digital and decarbonization, supported by restructuring and operational efficiencies.
Spirax Group Annual report: H2 2024
Spirax Group has published its H2 2024 annual report on March 11, 2025.
Spirax Group Annual report: H2 2024
Spirax Group has published its H2 2024 annual report on March 11, 2025.
Spirax Group Slides: H2 2024
Spirax Group has posted slides in relation to its H2 2024 quarterly earnings report, which was published on March 11, 2025.
Portfolio manager names Chinese and European stocks promising 'strong returns' despite market uncertainty
Pella Funds has increased its exposure to China by "well over 10%," in recent months, according to Jordan Cvetanovski. "Any stimulus which we expect to happen out of the Chinese authorities would be e...